Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111:491–500. https://doi.org/10.1016/j.ophtha.2003.06.014. discussion 500

Article  PubMed  Google Scholar 

Gaucher D, Bodaghi B, Charlotte F et al (2005) MALT-type B-cell lymphoma masquerading as scleritis or posterior uveitis. J Fr Ophtalmol 28:31–38. https://doi.org/10.1016/s0181-5512(05)81022-8

Article  CAS  PubMed  Google Scholar 

Dedieu D, Bouayed E, Brezin AP (2022) Hodgkin Lymphoma Associated Retinopathy: Report of a Case. Ocul Immunol Inflamm 30(1974–1976):20210513. https://doi.org/10.1080/09273948.2021.1912360

Article  Google Scholar 

Fredrick DR, Char DH, Ljung BM et al (1989) Solitary intraocular lymphoma as an initial presentation of widespread disease. Arch Ophthalmol 107:395–397. https://doi.org/10.1001/archopht.1989.01070010405034

Article  CAS  PubMed  Google Scholar 

Ramsay A, Lightman S (2001) Hypopyon uveitis. Surv Ophthalmol 46:1–18. https://doi.org/10.1016/s0039-6257(01)00231-4

Article  CAS  PubMed  Google Scholar 

Ayliffe W, Foster CS, Marcoux P et al (1995) Relapsing acute myeloid leukemia manifesting as hypopyon uveitis. Am J Ophthalmol 119:361–364. https://doi.org/10.1016/s0002-9394(14)71181-x

Article  CAS  PubMed  Google Scholar 

Kincaid MC, Green WR (1983) Ocular and orbital involvement in leukemia. Surv Ophthalmol 27:211–232. https://doi.org/10.1016/0039-6257(83)90123-6

Article  CAS  PubMed  Google Scholar 

Fraunfelder FW, Suhler EB, Fraunfelder FT (2010) Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol 29:26–29. https://doi.org/10.3109/15569520903427717

Article  PubMed  Google Scholar 

Holt HD, Hinkle DM, Falk NS et al (2014) Human papilloma virus vaccine associated uveitis. Curr Drug Saf 9:65–68. https://doi.org/10.2174/15748863113086660062

Article  CAS  PubMed  Google Scholar 

Blanche P, Decrette C, Sicard D (1994) Development of uveitis following vaccination for influenza. Clin Infect Dis 19:979. https://doi.org/10.1093/clinids/19.5.979

Article  CAS  PubMed  Google Scholar 

Islam SM, El-Sheikh HF, Tabbara KF (2000) Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases. Acta Ophthalmol Scand 78:590–592. https://doi.org/10.1034/j.1600-0420.2000.078005590.x

Article  CAS  PubMed  Google Scholar 

Lish A, Berman DH (1993) Tuberculin-triggered panuveitis in a patient recently treated for active pulmonary tuberculosis. Am J Ophthalmol 116:771–773. https://doi.org/10.1016/s0002-9394(14)73484-1

Article  CAS  PubMed  Google Scholar 

Guex-Crosier Y, Chamot L, Zografos L (2003) Chorioretinitis induced by intravesical Bacillus Calmette-Guerin (BCG) instillations for urinary bladder carcinoma. Klin Monbl Augenheilkd 220:193–195. https://doi.org/10.1055/s-2003-38179

Article  PubMed  Google Scholar 

Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T et al (2021) UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association. Retina 41:2462–2471. https://doi.org/10.1097/IAE.0000000000003277

Article  CAS  PubMed  Google Scholar 

Jain A, Kalamkar C (2021) COVID-19 vaccine-associated reactivation of uveitis. Indian J Ophthalmol 69:2899–2900. https://doi.org/10.4103/ijo.IJO_1435_21

Article  PubMed  PubMed Central  Google Scholar 

McLeod D, Kohner EM (1996) Cotton-wool spots and giant cell arteritis. Ophthalmology 103:701–702. https://doi.org/10.1016/s0161-6420(96)30627-1

Article  CAS  PubMed  Google Scholar 

Rai AS, Freund P, Margolin EA et al (2020) Numerous Cotton Wool Spots From Giant Cell Arteritis. J Clin Rheumatol 26:e124. https://doi.org/10.1097/RHU.0000000000000995

Article  PubMed  Google Scholar 

Moorthy RS, Moorthy MS, Cunningham ET Jr (2018) Drug-induced uveitis. Curr Opin Ophthalmol 29:588–603. https://doi.org/10.1097/ICU.0000000000000530

Article  PubMed  Google Scholar 

Agarwal M, Dutta Majumder P, Babu K et al (2020) Drug-induced uveitis: A review. Indian J Ophthalmol 68:1799–1807. https://doi.org/10.4103/ijo.IJO_816_20

Article  PubMed  PubMed Central  Google Scholar 

Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(336–341):20100218. https://doi.org/10.1016/j.ijsu.2010.02.007

Article  Google Scholar 

Brahmer JR, Tykodi SS, Chow LQ et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366(2455–2465):20120602. https://doi.org/10.1056/NEJMoa1200694

Article  CAS  Google Scholar 

Topalian SL, Hodi FS, Brahmer JR et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(2443–2454):20120602. https://doi.org/10.1056/NEJMoa1200690

Article  CAS  Google Scholar 

Antoun J, Titah C, Cochereau I (2016) Ocular and orbital side-effects of checkpoint inhibitors: a review article. Curr Opin Oncol 28:288–294. https://doi.org/10.1097/CCO.0000000000000296

Article  CAS  PubMed  Google Scholar 

Dow ER, Yung M, Tsui E (2021) Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes. Ocul Immunol Inflamm 29(203–211):20200820. https://doi.org/10.1080/09273948.2020.1781902

Article  CAS  Google Scholar 

Rapisuwon S, Izar B, Batenchuk C et al (2019) Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors. J Immunother Cancer 7(61):20190304. https://doi.org/10.1186/s40425-019-0533-0

Article  Google Scholar 

Crews J, Agarwal A, Jack L et al (2015) Ipilimumab-Associated Retinopathy. Ophthalmic Surg Lasers Imaging Retina 46:658–660. https://doi.org/10.3928/23258160-20150610-10

Article  PubMed  Google Scholar 

Mantopoulos D, Kendra KL, Letson AD et al (2015) Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma. JAMA Ophthalmol 133:965–967. https://doi.org/10.1001/jamaophthalmol.2015.1128

Article  PubMed  PubMed Central  Google Scholar 

Navarro-Perea C, Garcia-Gonzalez J, Perez-Blazquez E (2019) Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab. Indian J Ophthalmol 67:2075–2077. https://doi.org/10.4103/ijo.IJO_1161_19

Article  PubMed  PubMed Central  Google Scholar 

van der Noll R, Leijen S, Neuteboom GH et al (2013) Effect of inhibition of the FGFR-MAPK signaling pathway on the development of ocular toxicities. Cancer Treat Rev 39(664–672):20130219. https://doi.org/10.1016/j.ctrv.2013.01.003

Article  CAS  Google Scholar 

Urner-Bloch U, Urner M, Stieger P et al (2014) Transient MEK inhibitor-associated retinopathy in metastatic melanoma. Ann Oncol 25(1437–1441):20140526. https://doi.org/10.1093/annonc/mdu169

Article  Google Scholar 

van Dijk EH, van Herpen CM, Marinkovic M et al (2015) Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma. Ophthalmology 122(1907–1916):20150626. https://doi.org/10.1016/j.ophtha.2015.05.027

Article  Google Scholar 

Dreno B, Ribas A, Larkin J et al (2017) Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study. Ann Oncol 28:1137–1144. https://doi.org/10.1093/annonc/mdx040

Article  CAS  PubMed  Google Scholar 

de la Cruz-Merino L, Di Guardo L, Grob JJ et al (2017) Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study. J Transl Med 15(146):20170624. https://doi.org/10.1186/s12967-017-1246-0

Article  CAS  Google Scholar 

Stjepanovic N, Velazquez-Martin JP, Bedard PL (2016) Ocular toxicities of MEK inhibitors and other targeted therapies. Ann Oncol 27(998–1005):20160306. https://doi.org/10.1093/annonc/mdw100

Article  Google Scholar 

TE Yanagihara RT, Seitzman GD, Saraf SS (2022) A Case of Bilateral Multifocal Choroiditis Associated with BRAF/MEK Inhibitor Use for Metastatic Cutaneous Melanoma. Ocul Immunol Inflamm 30(7–8):2005–2009

Article  PubMed  Google Scholar 

Prensky C, Marlow E, Gupta M et al (2018) Reversible Macular Lesions in the Setting of Oral Pan-Fibroblast Growth Factor Inhibitor for the Treatment of Bladder Cancer. J VitreoRetinal Dis 2:111–114. https://doi.org/10.1177/2474126417751724

Article  Google Scholar 

Bostanci Ceran B, Ozates S (2020) Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol 258(1959–1963):20200606. https://doi.org/10.1007/s00417-020-04777-7

Article  CAS